No abstract available
Keywords:
NAFLD; NASH; drug development; elafibranor; obeticholic acid; therapy.
MeSH terms
-
Drug Design*
-
Humans
-
Non-alcoholic Fatty Liver Disease / drug therapy*
-
Non-alcoholic Fatty Liver Disease / epidemiology
-
Non-alcoholic Fatty Liver Disease / physiopathology